Scarica l'app Stockscreener
357.65
0.57%
-2.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WST Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
West Pharmaceutical Services Inc Borsa (WST) Ultime notizie
West Pharmaceutical Services (WST) Enters Strategic Agreements w - GuruFocus
West Pharmaceutical (NYSE: WST) inks 10-year Daikyo licensing, distribution deal - Stock Titan
Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry - Yahoo Finance
3 Reasons WST is Risky and 1 Stock to Buy Instead - Yahoo Finance
BNP Paribas Initiates West Pharmaceutical Services at Outperform With $447 Price Target - Moomoo
West Pharmaceutical Services, Inc. Stock 12‑Month Price Target Raised to $383.93, Implies 9% Upside - TradingView
West Synchrony Prefillable Syringe System Available at CPHI Southeast Asia - BioSpectrum Asia
WST completes SmartDose sale to AbbVie to focus on core growth - MSN
West Pharmaceutical stock holds steady as drug-delivery leader builds on long-term growth story - Ad-hoc-news.de
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
West Pharmaceutical Services (WST) Sells SmartDose Rights To AbbVie To Refocus Its Business - Yahoo Finance
Resmed Divests MatrixCare Business to Sharpen Focus on Connected Care - TradingView
West Pharmaceutical stock reflects steady demand for drug delivery components - Ad-hoc-news.de
The Bull Case For West Pharmaceutical Services (WST) Could Change Following Its Q1 2026 Earnings Beat And UpgradesLearn Why - Sahm
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharma Price Target Raised to $365.00/Share From $325.00 by Morgan Stanley - Moomoo
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now - TradingView
Morgan Stanley Adjusts Price Target on West Pharmaceutical Services to $365 From $325 - marketscreener.com
West Pharmaceutical Services, Inc. Stock 12‑Month Price Target Raised to $370.23, Implies 5% Upside - TradingView
WST Completes SmartDose Sale to AbbVie to Focus on Core Growth - Yahoo Finance
Morgan Stanley Maintains West Pharmaceutical Services(WST.US) With Hold Rating, Raises Target Price to $365 - Moomoo
West Pharmaceutical outlines long-term growth drivers as investors track U.S. healthcare demand - ad-hoc-news.de
West Launches Synchrony™ Prefillable Syringe System for Biologics and Vaccines in Southeast Asia - BioPharma APAC
WST stock up nearly 33% YTD: Will the uptrend continue in the rest of 2026? - MSN
The Daikyo D2F Series PlungerWest Pharmaceutical focuses on high-barrier safety for prefilled syr - Ad-hoc-news.de
West Pharmaceutical Services (WST) Is Up 4.24% in One Week: What You Should Know - Yahoo Finance
Here's Why You Should Retain AMN Stock in Your Portfolio for Now - TradingView
West to Host Second-Quarter 2026 Conference Call - BioSpace
WST Maintains Rating by Evercore ISI Group -- Price Target Raises to $410 - GuruFocus
West Pharmaceutical Services Inc. stock underperforms Monday when compared to competitors - MarketWatch
West Pharmaceutical updates strategy as global demand for drug delivery grows - AD HOC NEWS
West Pharmaceutical Services (WST) Stock Looks Overvalued Despite Upcoming Q2 Earnings - Yahoo Finance
WST Stock Up Nearly 33% YTD: Will the Uptrend Continue in the Rest of 2026? - TradingView
Did You Lose Money on West Pharmaceutical Services, Inc. (WST)? L - The National Law Review
West Pharmaceutical Services Stock 10-Day Winning Spree: Stock Climbs 13% - Trefis
West Pharmaceutical rises on upbeat results, guidance raise - MSN
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now - TradingView
West completes sale of on-body drug delivery device to AbbVie - Drug Delivery Business
West Pharmaceutical Services Stock Rockets 13% With 9-Day Winning Streak - Trefis
What to Expect From West Pharmaceutical Services' Q2 2026 Earnings Report - Yahoo Finance
KeyBanc Maintains West Pharmaceutical Services(WST.US) With Buy Rating, Raises Target Price to $390 - Moomoo
West Pharmaceutical Services (WST) Is Up 6.7% After 21% Revenue Growth on Drug Delivery Demand - Sahm
West Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System - Sahm
KeyBanc Adjusts PT on West Pharmaceutical Services to $390 From $350, Maintains Overweight Rating - marketscreener.com
West Pharmaceutical Services stock hits 52-week high at 363.38 USD - Investing.com India
West Pharmaceutical completes sale of SmartDose 3.5mL system By Investing.com - Investing.com Australia
Form 4 West Pharmaceutical Services Inc For: 1 July By Investing.com - Investing.com Canada
West Pharmaceutical (WST) director awarded new phantom stock units and RSUs - Stock Titan
West Pharmaceutical completes sale of SmartDose 3.5mL system - Investing.com
Westar™ RS LyoVials from West Pharmaceuticalmodular containment for complex injectables - AD HOC NEWS
West Pharmaceutical Services (WST) Is Up 6.7% After 21% Revenue Jump On Injectable DemandHas The Bull Case Changed? - Yahoo Finance
West Pharmaceutical Services, Inc.'s stock price skyrockets to $359.00, boasting a promising 1.22% increase - Smartkarma
Here's Why You Should Add BrightSpring Stock to Your Portfolio Now - TradingView
WST Technical Analysis & Stock Price Forecast - Intellectia AI
The SmartDose Gen. II injector from West Pharmaceutical Services Inc.wearable biologics delivery - AD HOC NEWS
West Pharmaceutical Services Inc. stock rises Monday, still underperforms market - MarketWatch
2.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):